| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 350 | $80 | $26.7K |
| 91320 | This code represents a SARS–CoV–2 vaccine product (tris–sucrose formulation) administered by intramuscular injection to reduce the patient’s risk of contracting COVID–19. The dosage is 30 mcg/0.3 mL. | 100 | $130 | $12.3K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 220 | $60 | $12.2K |
| 99215 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the… | 110 | $110 | $11.9K |
| 90677 | This code represents a vaccine product administered intramuscularly to protect against pneumococcal disease, a bacterial infection. This is a 20–valent vaccine, protecting against 20 strains of the… | 40 | $280 | $10.3K |
| 90662 | This code represents a flu vaccine product that is a split virus type, contains no preservatives, and has enhanced effectiveness due to a higher antigen content. It is administered as an injection… | 130 | $70 | $8.9K |
| 36415 | In this procedure, the provider inserts a needle into a vein to collect a blood sample. | 530 | $10 | $4.2K |
| 83721 | The lab analyst performs a test to directly measure the low density lipoprotein, LDL, cholesterol in a patient specimen. | 410 | $10 | $4.1K |
| 87084 | The lab analyst cultures a patient specimen on a test medium designed to grow only a specific pathogenic organism, and estimates the level of colony growth using a density chart. | 150 | $30 | $3.9K |
| G0008 | Administration of influenza virus vaccine | 130 | $30 | $3.7K |